Tequin Hyperglycemia and Hypoglycemia Lawsuits

Tequin (gatifloxacin) by pharmaceutical company Bristol-Myers Squibb, is to be pulled from the market. On May 1, 2006, Bristol-Myers Squibb stated that it will cease making and selling its antibiotic Tequin. Approved by the FDA in 1999, Tequin has been plagued by serious blood-sugar complications such as serious cases of diabetes and other potentially fatal blood sugar abnormalities. The consumer group Public Citizen claims Tequin carries greater health risks but fewer benefits over similar drugs.

Tequin (gatifloxacin) Information

Tequin is an antibiotic that is commonly used to treat adults with lung, sinus and urinary tract infections as well as certain sexually transmitted diseases. Tequin is an antibiotic in the class of drugs called fluoroquinolones, which also contains Cipro, Levaquin and Avelox.

In early 2006, Bristol Myers Squibb and the FDA added a warning to the Tequin label notifying diabetics not to take the drug. However, the study's author said the blood-sugar problem can happen to anybody whether they have diabetes or not, and it usually occurs within a few days of taking Tequin. The risk of the drug might be even greater than the study revealed because it was only based on hospital data. If a consumer suffered these serious blood sugar abnormalities or other side effects, but wasn't hospitalized, or died, they would not have been included in the study data.

Legal Help for Tequin Hyperglycemia and Hypoglycemia Victims

If you or a loved one have been diagnosed with hyperglycemia or hypoglycemia, or experienced a blood sugar disorder, during or after taking Tequin, contact The Willis Law Firm today. We provide a free consultation for Tequin victims and their families. Fill out our Free Online Case Evaluation or call us toll free at: 1-800-883-9858.